[The role of long-acting release (LAR) depot octreotide as adjuvant management of short bowel disease].

Departamento de Apoyo Nutricional, Hospital de Especialidades, Centro Médico Nacional de Occidente, IMSS, Guadalajara. oafll@hotmail.com

Cirugia y cirujanos. 2004;(5):379-86
Full text from:

Abstract

In the Americas, the Pan American Health Organization supports strategies for the appropriate control and elimination of vaccine-preventable diseases, especially if the strategies are designed to reduce health inequities, strengthen the political commitment for immunization services, and promote the culture of prevention. In September 2003, the 44th Directing Council of the Pan American Health Organization adopted a goal to eliminate rubella and congenital rubella syndrome by 2010. One of the main objectives of this initiative is improving women's health, consistent with achieving the Millennium Development Goals. An important component of rubella elimination is conducting vaccination campaigns for men and women of childbearing age to reduce rapidly the number of people susceptible to rubella infection. From 1998 to 2002, the English-speaking Caribbean, Chile, Costa Rica, Brazil, and Honduras conducted mass rubella vaccination campaigns aimed at adults. Vaccination coverage reached >95% in each country with an exception of the Caribbean, where the coverage was 80%.

Methodological quality

Publication Type : Clinical Trial

Metadata